200 Participants Needed

Exercise Intensity for Cardiorespiratory Fitness

(REVISE Trial)

RR
Overseen ByRobert Ross, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Robert Ross, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

In this proposal, the investigators challenge the assumption that following the physical activity guidelines implies benefit for ALL adults, and that if benefit is not achieved in response to first line therapy, it will be by simply exercising more. Thus, for improving cardiorespiratory fitness and cardiometabolic risk factors, unanswered questions include: 1) To what extent, regardless of increasing exercise intensity or amount, is exercise not associated with benefit? Demonstration of a resistance to benefit through exercise in a substantial number of adults would be a novel and important finding, would counter the assumptions of many if not most health care practitioners, and could have immediate and direct application in all health care settings. 2) To what extent will non-responders to first line therapy (150 min/wk) be required to increase exercise intensity or amount to achieve benefit? 3) To what extent will failure to improve CRF segregate (be associate with) with cardiometabolic risk factors? The investigators propose that adults who remain exercise resistant for improvement in CRF and cardiometabolic risk despite increasing amount or intensity are at high risk of metabolic disease and consequently, are candidates for alternative treatment strategies.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Exercise Intensity for Cardiorespiratory Fitness?

Research shows that high-intensity interval training (HIIT) can significantly improve peak oxygen uptake, which is a measure of cardiorespiratory fitness, in various patient groups, including heart transplant recipients and those with coronary artery disease. This suggests that similar high-intensity exercise treatments could be effective in improving fitness levels.12345

Is high-intensity interval training (HIIT) safe for people with cardiovascular and metabolic diseases?

Research shows that high-intensity interval training (HIIT) is generally safe for people with cardiovascular and metabolic diseases, with a low rate of major adverse events. However, caution is advised, and it is important for individuals to be clinically stable, have prior experience with moderate exercise, and be supervised during sessions.678910

How does the exercise intensity treatment for cardiorespiratory fitness differ from other treatments?

This treatment is unique because it involves varying levels of exercise intensity and volume, such as high-intensity interval training (HIIT) and low-volume high-intensity exercise, which can potentially improve cardiorespiratory fitness more effectively than moderate-intensity continuous training. Unlike other treatments, it focuses on short bursts of intense activity interspersed with rest, which may lead to different metabolic adaptations and improvements in fitness.1112131415

Research Team

RR

Robert Ross, PhD

Principal Investigator

Queen's University

Eligibility Criteria

This trial is for adults who lead a sedentary lifestyle, exercising no more than once a week, have had a stable weight for the past 6 months, and have a BMI between 20-40. It's not suitable for individuals with diabetes, current smokers, those planning to move soon or anyone with physical impairments that make exercise difficult or unsafe.

Inclusion Criteria

You do not engage in physical activity more than once a week.
Your body mass index (BMI) falls between 20 and 40 kg/m2.
Weight stable (± 2 kg) for 6 months prior to the beginning of the study

Exclusion Criteria

Plan to move from the area in next 8 months
Physical impairment which would make the intervention very difficult or unsafe according to doctor's advice
I have diabetes and I currently smoke.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

First Line Therapy

Participants engage in 150 minutes per week of moderate physical activity (MPA) for 16 weeks to assess initial response in cardiorespiratory fitness (CRF) and cardiometabolic risk factors.

16 weeks
4 visits (in-person) every 4 weeks

Increased Exercise Intensity/Amount

Participants who do not respond to first line therapy increase exercise intensity or amount for an additional 16 weeks to evaluate changes in CRF and cardiometabolic risk factors.

16 weeks
4 visits (in-person) every 4 weeks

Follow-up

Participants are monitored for safety and effectiveness after the exercise intervention phases.

4 weeks

Treatment Details

Interventions

  • High amount, high intensity exercise
  • Low amount, high intensity exercise
  • Low amount, low intensity exercise
Trial Overview The study is testing how different amounts and intensities of exercise affect cardiorespiratory fitness and cardiometabolic risk factors. Participants will be assigned to one of three groups: low amount/low intensity exercise, low amount/high intensity exercise, or high amount/high intensity exercise.
Participant Groups
4Treatment groups
Experimental Treatment
Active Control
Group I: Low amount, low intensity exerciseExperimental Treatment1 Intervention
exercise dose (amount and intensity) will be controlled.
Group II: Low amount, high intensity exerciseExperimental Treatment1 Intervention
exercise dose (amount and intensity) will be controlled.
Group III: High amount, high intensity exerciseExperimental Treatment1 Intervention
exercise dose (amount and intensity) will be controlled.
Group IV: ControlActive Control1 Intervention
no exercise intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Robert Ross, PhD

Lead Sponsor

Robert Ross, PhD

Lead Sponsor

Queen's University

Lead Sponsor

Trials
382
Recruited
122,000+

Findings from Research

A 1-year high-intensity interval training (HIIT) program significantly improved exercise capacity in heart transplant recipients, increasing their VO2peak levels to 89% of predicted values compared to 82.5% in the control group.
The study involved 48 stable heart transplant recipients, and despite the improvements in exercise capacity, there were no adverse effects on cardiac function, indicating that HIIT is a safe and effective exercise option for this population.
High-intensity interval training improves peak oxygen uptake and muscular exercise capacity in heart transplant recipients.Nytrøen, K., Rustad, LA., Aukrust, P., et al.[2023]
High-intensity interval training (HIIT) is a feasible exercise strategy for breast cancer patients undergoing anthracycline-based chemotherapy, with 80% of participants attending the majority of sessions and completing an average of 78 minutes of exercise per week.
The HIIT intervention successfully maintained cardiorespiratory fitness (VO2max) in participants, while the control group experienced a significant decline in VO2max, highlighting the potential of HIIT to counteract the negative effects of chemotherapy on fitness.
Feasibility of high intensity interval training in patients with breast Cancer undergoing anthracycline chemotherapy: a randomized pilot trial.Lee, K., Kang, I., Mack, WJ., et al.[2023]
In a study of 21 stable coronary artery disease (CAD) patients, high-intensity aerobic interval exercise (80-90% of VO2peak) resulted in a significant 17.9% increase in peak oxygen uptake (VO2peak) compared to a 7.9% increase with moderate-intensity exercise (50-60% of VO2peak) over 10 weeks.
The findings suggest that high-intensity exercise is more effective than moderate exercise for improving VO2peak in CAD patients, which is important for reducing the risk of cardiovascular disease and mortality.
High intensity aerobic interval exercise is superior to moderate intensity exercise for increasing aerobic capacity in patients with coronary artery disease.Rognmo, Ø., Hetland, E., Helgerud, J., et al.[2022]

References

High-intensity interval training improves peak oxygen uptake and muscular exercise capacity in heart transplant recipients. [2023]
Feasibility of high intensity interval training in patients with breast Cancer undergoing anthracycline chemotherapy: a randomized pilot trial. [2023]
High intensity aerobic interval exercise is superior to moderate intensity exercise for increasing aerobic capacity in patients with coronary artery disease. [2022]
Training level comparison study. Effect of high and low intensity exercise on ventilatory threshold in men with coronary artery disease. [2022]
Aerobic interval training increases peak oxygen uptake more than usual care exercise training in myocardial infarction patients: a randomized controlled study. [2022]
High-Intensity Interval Training for Patients With Cardiovascular Disease-Is It Safe? A Systematic Review. [2021]
What Doesn't Kill You Makes You Fitter: A Systematic Review of High-Intensity Interval Exercise for Patients with Cardiovascular and Metabolic Diseases. [2022]
Chronotropic Responses to Exercise and Recovery in Myocardial Infarction Patients Taking β-Blockers Following Aerobic High-Intensity Interval Training: AN INTERFARCT STUDY. [2022]
Low-volume high-intensity interval training for cardiometabolic health. [2022]
Effects of low-volume high-intensity interval training in a community setting: a pilot study. [2018]
11.United Statespubmed.ncbi.nlm.nih.gov
Comparison of High-Intensity Training Versus Moderate-Intensity Continuous Training on Cardiorespiratory Fitness and Body Fat Percentage in Persons With Overweight or Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. [2022]
Effects of high-intensity interval training compared to moderate-intensity continuous training on maximal oxygen consumption and blood pressure in healthy men: A randomized controlled trial [2020]
Effects of High-Intensity Interval and Moderate-Intensity Continuous Exercise on Physical Activity and Sedentary Behavior Levels in Inactive Obese Males: A Crossover Trial. [2020]
Training for intense exercise performance: high-intensity or high-volume training? [2022]
15.United Statespubmed.ncbi.nlm.nih.gov
Is determination of exercise intensities as percentages of VO2max or HRmax adequate? [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security